SCHEMBL7988958

SCHEMBL7988958

Cc1cccc(Cn2cnc3nc(-c4cccc(F)c4)nc(O)c32)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
HPGD P15428 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
BRD4 O60885 1/20 0.39
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.37
HTT P42858 1/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2B Q13224 2/20 0.37
DPP4 P27487 1/20 0.37
TP53 P04637 2/20 0.37
MET P08581 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TLR9 Q9NR96 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991669 0.92 HDAC1 (0.38) CYP11B1CYP11B2BRD4
SCHEMBL7988567 0.91 HPGD (0.44) ALDH1A1CYP11B1CYP11B2HPGDPOLB
SCHEMBL7974469 0.91 HDAC1 (0.40) CYP11B1CYP11B2MEN1KMT2ASMN1; SMN2
SCHEMBL7974247 0.89 CYP11B1 (0.44) ALDH1A1CYP11B1CYP11B2HPGDMEN1
SCHEMBL7974268 0.89 CYP11B1 (0.48) ALDH1A1CYP11B1CYP11B2HPGDMEN1
SCHEMBL7987253 0.89 HPGDS (0.40) ALDH1A1CYP11B1CYP11B2HPGDSMN1; SMN2
SCHEMBL7991557 0.88 LMNA (0.43) ALDH1A1CYP11B1CYP11B2HPGDMEN1
SCHEMBL7975240 0.88 ALDH1A1 (0.42) ALDH1A1CYP11B1CYP11B2HPGDPOLB
SCHEMBL7987310 0.88 YTHDC1 (0.41) POLBSMN1; SMN2LMNAHTTGRIN1
SCHEMBL7991635 0.87 IDO1 (0.37) CYP11B1CYP11B2BRD4MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed